Item 2.01 Completion of Acquisition or Disposition of Assets.
On
The unaudited pro forma financial information giving effect to the BioPharma sale transaction is filed herewith as Exhibit 99.
Item 9.01 Financial Statements and Exhibits.
(b) Pro Forma Financial Information.
The following unaudited pro forma financial information of the Company is filed as Exhibit 99 to this Report on Form 8-K and is incorporated herein by reference:
• Unaudited Pro Forma Condensed Consolidated Statement of Financial Position as ofDecember 31, 2019 . • Unaudited Pro Forma Condensed Consolidated Statement of Earnings (Loss) for the year endedDecember 31, 2019 .
• Notes to the Unaudited Pro Forma Condensed Consolidated Financial Statements.
(d) Exhibits.
99 . General Electric Company Unaudited Pro Forma Condensed Consolidated Financial Statements.
104. The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
(2)
--------------------------------------------------------------------------------
© Edgar Online, source